BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22272367)

  • 1. Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.
    Mpanya A; Hendrickx D; Vuna M; Kanyinda A; Lumbala C; Tshilombo V; Mitashi P; Luboya O; Kande V; Boelaert M; Lefèvre P; Lutumba P
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1467. PubMed ID: 22272367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.
    Mpanya A; Hendrickx D; Baloji S; Lumbala C; da Luz RI; Boelaert M; Lutumba P
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003686. PubMed ID: 25856578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.
    Robays J; Lefèvre P; Lutumba P; Lubanza S; Kande Betu Ku Mesu V; Van der Stuyft P; Boelaert M
    Trop Med Int Health; 2007 Feb; 12(2):290-8. PubMed ID: 17300638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.
    Lumbala C; Simarro PP; Cecchi G; Paone M; Franco JR; Kande Betu Ku Mesu V; Makabuza J; Diarra A; Chansy S; Priotto G; Mattioli RC; Jannin JG
    Int J Health Geogr; 2015 Jun; 14():20. PubMed ID: 26047813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program.
    Hasker E; Mpanya A; Makabuza J; Mbo F; Lumbala C; Kumpel J; Claeys Y; Kande V; Ravinetto R; Menten J; Lutumba P; Boelaert M
    Trop Med Int Health; 2012 Sep; 17(9):1127-32. PubMed ID: 22809002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions.
    Mulenga P; Boelaert M; Lutumba P; Vander Kelen C; Coppieters Y; Chenge F; Lumbala C; Luboya O; Mpanya A
    Am J Trop Med Hyg; 2019 Apr; 100(4):899-906. PubMed ID: 30719963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
    Robays J; Nyamowala G; Sese C; Betu Ku Mesu Kande V; Lutumba P; Van der Veken W; Boelaert M
    Emerg Infect Dis; 2008 Jun; 14(6):966-7. PubMed ID: 18507916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the heart of darkness: sleeping sickness in Zaire.
    Ekwanzala M; Pépin J; Khonde N; Molisho S; Bruneel H; De Wals P
    Lancet; 1996 Nov; 348(9039):1427-30. PubMed ID: 8937285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
    Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleeping sickness in Zaire.
    van Hove D
    Lancet; 1997 Feb; 349(9049):438. PubMed ID: 9033508
    [No Abstract]   [Full Text] [Related]  

  • 12. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
    Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
    Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo.
    Snijders R; Fukinsia A; Claeys Y; Hasker E; Mpanya A; Miaka E; Meheus F; Boelaert M
    Emerg Infect Dis; 2021 Aug; 27(8):2144-2153. PubMed ID: 34287133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, behaviours, practices and beliefs regarding Human African Trypanosomiasis (HAT) among inhabitants of Kinshasa (Democratic Republic of Congo).
    Tshimungu K; Kalambayi BB; Kiyombo M; Okenge LN; Mol PD
    Sante; 2008; 18(3):141-7. PubMed ID: 19359235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.
    Robays J; Bilengue MM; Van der Stuyft P; Boelaert M
    Trop Med Int Health; 2004 May; 9(5):542-50. PubMed ID: 15117297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo.
    Rock KS; Torr SJ; Lumbala C; Keeling MJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005162. PubMed ID: 28056016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials as disease control? The political economy of sleeping sickness in the Democratic Republic of the Congo (1996-2016).
    Falisse JB; Mpanya A
    Soc Sci Med; 2022 Apr; 299():114882. PubMed ID: 35299059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.
    Hasker E; Lumbala C; Mbo F; Mpanya A; Kande V; Lutumba P; Boelaert M
    Trop Med Int Health; 2011 Jul; 16(7):869-74. PubMed ID: 21447063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo.
    Snijders R; Fukinsia A; Claeys Y; Mpanya A; Hasker E; Meheus F; Miaka E; Boelaert M
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008832. PubMed ID: 33315896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.
    Lutumba P; Robays J; Miaka mia Bilenge C; Mesu VK; Molisho D; Declercq J; Van der Veken W; Meheus F; Jannin J; Boelaert M
    Emerg Infect Dis; 2005 Sep; 11(9):1382-8. PubMed ID: 16229766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.